gastroparesis from glp 1 Lawsuit - Ozempic, Wegovy & Mounjaro Implications of the glp-1 era

When that pathway is disrupted by obesity, aging, or poor diet GLP-1 production downstream suffers

Pancreatic Health (Amylase and Lipase) Though very rare, inflammation of the pancreas (pancreatitis) is a noted potential risk for this class of medication

GLP-1 RAs may attenuate inflammatory response by down-regulating NF-kB signalling

And patients want to access these medications at an affordable price point. Many insurers are narrowing eligibility for GLP-1 coverage to high-risk patientstypically those with Type 2 diabetes, or with a BMI over a certain threshold and a weight-related comorbidity (e.g., hypertension, sleep apnea)

In addition, liraglutide has been shown to significantly modify lipoprotein metabolism by reducing chylomicron production

Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance